Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Margin(%) 5.497.707.20-2.112.41

What is the latest EBIT Margin ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Margin ratio of SOTAC PHARMACEUTICALS is 5.49 based on Mar2024 Consolidated results.
Year EBIT Margin
Mar20245.49
Mar20237.70
Mar20227.20
Mar2021-2.11
Mar20202.41

How is EBIT Margin of SOTAC PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2024 5.49
-28.70
Mar2023 7.7
6.94
Mar2022 7.2
Positive
Mar2021 -2.11
Negative
Mar2020 2.41 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Margin ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹121.5 Cr -1.1% -20% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,684.0 Cr 2.9% 6.4% 48.1% Stock Analytics
DIVIS LABORATORIES ₹155,935.0 Cr 0.5% -2.1% 59.2% Stock Analytics
CIPLA ₹121,639.0 Cr 2.3% 1% 20.6% Stock Analytics
DR REDDYS LABORATORIES ₹115,931.0 Cr 3.5% 15.7% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,876.4 Cr -0.1% 2.3% 41.1% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-1.1%

-20%

-8.1%

SENSEX

-0.7%

-1.6%

11.1%


You may also like the below Video Courses